INTERNATIONAL PATENT: JOHNSON & JOHNSON ENTERPRISE INNOVATION INC., JOHNSON & JOHNSON (CHINA) INVESTMENT LTD. FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITIONS OF AN A2A RECEPTOR ANTAGONIST"

GENEVA, June 20 -- JOHNSON & JOHNSON ENTERPRISE INNOVATION INC. (One Johnson & Johnson Plaza, New BrunswickNew Jersey 08933), JOHNSON & JOHNSON (CHINA) INVESTMENT LTD. (2101, No.1 Building, 65 Gui Qing RoadXuhui District, Shanghai 200233) filed a patent application (PCT/CN2023/138534) for "PHARMACEUTICAL COMPOSITIONS OF AN A2A RECEPTOR ANTAGONIST" on Dec 13, 2023. With publication no. WO/2025/123253, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHU, Alan (8F, Building A, Xinyan Mansion, No. 65 Guiqing RoadXuhui Distric...